| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Lepzacitinib manufacturers
- Lepzacitinib
-
-
2026-07-27
- CAS:2321488-47-3
- Purity:
- Supply Ability: 10g
|
| | Lepzacitinib Basic information |
| Product Name: | Lepzacitinib | | Synonyms: | Lepzacitinib;1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 4-[[(3R)-1-(2-cyanoacetyl)-3-piperidinyl]amino]-, ethyl ester | | CAS: | 2321488-47-3 | | MF: | C18H21N5O3 | | MW: | 355.39 | | EINECS: | | | Product Categories: | | | Mol File: | 2321488-47-3.mol |  |
| | Lepzacitinib Chemical Properties |
| density | 1.348±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | -0.474±0.40(predicted) | | form | Solid | | color | Off-white to light yellow |
| | Lepzacitinib Usage And Synthesis |
| Uses | Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1]. | | References | [1] Anderson, et al. Preparation of substituted pyrrolopyridine compounds as JAK inhibitors. World Intellectual Property Organization, WO2019090158 A1 2019-05-09. |
| | Lepzacitinib Preparation Products And Raw materials |
|